Hudson Bay Capital Management
RCUS icon

Hudson Bay Capital Management’s Arcus Biosciences RCUS Stock Holding History

Hudson Bay Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.32M Sell
140,000
-216,535
-61% -$5.35M 0.01% 605
2026
Q1 		$7.7M Buy
356,535
+116,535
+49% +$2.52M 0.03% 372
2025
Q4 		$5.72M Sell
240,000
-100,000
-29% -$2.04M 0.02% 471
2025
Q3 		$4.62M Sell
340,000
-90,000
-21% -$936K 0.02% 568
2025
Q2 		$3.5M Buy
430,000
+61,450
+17% +$525K 0.01% 648
2025
Q1 		$2.89M Buy
368,550
+198,550
+117% +$2.3M 0.01% 744
2024
Q4 		$2.53M Sell
170,000
-5,000
-3% -$81.7K 0.01% 614
2024
Q3 		$2.68M Buy
175,000
+15,000
+9% +$237K 0.01% 530
2024
Q2 		$2.44M Sell
160,000
-5,000
-3% -$80.7K 0.01% 503
2024
Q1 		$3.12M Sell
165,000
-5,000
-3% -$86.5K 0.02% 395
2023
Q4 		$3.25M Buy
170,000
+90,000
+113% +$1.44M 0.02% 372
2023
Q3 		$1.44M Sell
80,000
-35,000
-30% -$703K 0.01% 521
2023
Q2 		$2.34M Buy
115,000
+200
+0.2% +$3.81K 0.02% 483
2023
Q1 		$2.09M Buy
114,800
+64,800
+130% +$1.24M 0.02% 514
2022
Q4 		$1.03M Buy
50,000
+25,000
+100% +$688K 0.01% 679
2022
Q3 		$654K Sell
25,000
-6,000
-19% -$159K 0.01% 877
2022
Q2 		$786K Buy
31,000
+21,000
+210% +$514K 0.01% 958
2022
Q1 		$316K Buy
+10,000
New +$335K ﹤0.01% 895
2020
Q4 		– Sell
-85,000
Closed -$1.46M – 686
2020
Q3 		$1.46M Sell
85,000
-25,000
-23% -$559K 0.02% 389
2020
Q2 		$2.72M Buy
+110,000
New +$2.97M 0.05% 275

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Hudson Bay Capital Management's RCUS Position: Q2 2026 in Review

Hudson Bay Capital Management reduced its Arcus Biosciences (RCUS) stake by 61% in Q2 2026, selling an estimated $5.35M and leaving 140,000 shares worth $4.32M. The position accounts for 0.01% of the portfolio, ranked #605.

Hudson Bay Capital Management first reported a position in RCUS in Q2 2020 and has held it in 20 quarters since. The position peaked at $7.7M in Q1 2026. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Hudson Bay Capital Management held 140,000 shares of Arcus Biosciences worth $4.32M as of Q2 2026.
  • Hudson Bay Capital Management sold 216,535 Arcus Biosciences shares in Q2 2026, an estimated $5.35M.
  • Arcus Biosciences made up 0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #605 holding.
  • Hudson Bay Capital Management first reported a position in Arcus Biosciences in Q2 2020 and has held it in 20 quarters since.
  • Hudson Bay Capital Management's Arcus Biosciences position peaked at $7.7M in Q1 2026.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.